Trial Profile
Study investigating disease relapse rates and virological response after discontinuation of entecavir treatment in chronic hepatitis B patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Dec 2015
Price :
$35
*
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 08 Dec 2015 New trial record